The Chicago Tribune recently ran a piece focused on our Insight Accelerator Labs accelerator program, which helps medical startups go from conceptualization to achieving a market-ready product.
Insight Accelerator Labs Executive Steve McPhilliamy told the Tribune how the project will work with several Chicago universities in order to find select companies and offer them an residency at Insight’s Ravenswood office, allowing them to collaborate with Insight’s proven product development team, and also assist them with mentorship and financial connections in order to make their ideas successful.
Insight Labs charter startup is BriteSeed, a new surgical based imaging technology company that helps surgeons prevent accidental cuts into arteries. BriteSeed has begun to work with the Insight team to evolve their Intellectual Property into physical viable solutions.
A PDF of the article is available via the link below if you do not already have a free Chicago Tribune subscription.
If you do have a free Chicago Tribune subscription, visit the Chicago Tribune online to read the full article.